PMV Pharmaceuticals, Inc.PMVPNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+4.1%
5Y CAGR+20.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+4.1%/yr
vs +41.8%/yr prior
5Y CAGR
+20.0%/yr
Recent deceleration
Acceleration
-37.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
7 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $86.11M | +2.1% |
| 2024 | $84.30M | +6.9% |
| 2023 | $78.88M | +3.3% |
| 2022 | $76.39M | +34.0% |
| 2021 | $57.01M | +64.7% |
| 2020 | $34.62M | +31.9% |
| 2019 | $26.25M | +38.9% |
| 2018 | $18.89M | - |